Huttner, A., Agnandji, S. T., Combescure, C., Fernandes, J. F., Bache, E. B., Kabwende, L., . . . Siegrist, C. (2018). Determinants of antibody persistence across doses and continents after single-dose rVSV-ZEBOV vaccination for Ebola virus disease: An observational cohort study. Lancet Infect Dis.
Chicago Style citaatHuttner, Angela, et al. "Determinants of Antibody Persistence Across Doses and Continents After Single-dose RVSV-ZEBOV Vaccination for Ebola Virus Disease: An Observational Cohort Study." Lancet Infect Dis 2018.
MLA citatieHuttner, Angela, et al. "Determinants of Antibody Persistence Across Doses and Continents After Single-dose RVSV-ZEBOV Vaccination for Ebola Virus Disease: An Observational Cohort Study." Lancet Infect Dis 2018.